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Usefulness of Denoising process 
to Depict Myopic choroidal 
neovascularisation Using a Single 
optical coherence tomography 
Angiography image
Yuka Sawai1, Manabu Miyata  1*, Akihito Uji1, Sotaro ooto1, Hiroshi tamura  1,  
naoko Ueda-Arakawa1, Yuki Muraoka1, Masahiro Miyake1, Ayako takahashi1, 
Yu Kawashima1, Shin Kadomoto1, Yasuyuki oritani1, Kentaro Kawai1, Kenji Yamashiro  1,2 & 
Akitaka tsujikawa1
Quality of single optical coherence tomography angiography (octA) images of myopic choroidal 
neovascularisation (mcnV) is poorer than in averaged images, although obtaining averaged images 
takes much time. this study evaluated the clinical usefulness of novel denoising process for depicting 
mCNV. This study included 20 eyes of 20 patients with mCNV. Ten en face images taken in a 3 × 3 mm 
macular cube were obtained from outer-retina-to-choriocapillaris layer. three image types were 
prepared for analysis; single images before and after the denoising process accomplished deep learning 
(single and denoising groups, respectively) and up to 10 images were averaged (averaging group). 
pairwise comparisons showed vessel density, vessel length density, and fractal dimension (fD) were 
higher; whereas, vessel density index (VDi) was lower in single group than in denoising and averaging 
groups. Detectable cnV indices, contrast-to-nose ratio, and cnV diagnostic scores were higher in 
denoising and averaging groups than in single group. No significant differences were detected in VDI, 
fD, or cnV diagnostic scores between denoising and averaging groups. the denoising process can 
utilise single octA images to provide results comparable to averaged octA images, which is clinically 
useful for shortening examination times with quality similar to averaging.
Myopic choroidal neovascularisation (mCNV) is one of the commonest vision-threatening complications 
in highly myopic eyes1. Early mCNV treatment with an intravitreal anti-vascular endothelial growth factor 
(anti-VEGF) agent is safe and effective2–4. Anti-VEGF therapy has become the standard-of-care and recom-
mended first-line treatment option for mCNV5. Therefore, early detection of mCNV has become essential to 
prevent mCNV complications.
Optical coherence tomography angiography (OCTA) is a novel, noninvasive modality that facilitates 
depth-resolved visualisation of retinal and choroidal blood flow without a dye injection, which may induce 
general complications6. A previous study reported the usefulness of OCTA in detecting mCNV7. Furthermore, 
OCTA-derived parameters of vessel length density (VLD) and fractal dimension (FD) can be predictors of poor 
visual outcomes after anti-VEGF therapy in mCNV8. Recently, some reports showed that averaging multiple en 
face OCTA images improves image quality9–12. However, it takes longer to obtain many OCTA images for aver-
aging than to take a single OCTA image. A novel OCTA device with denoising process function accomplished by 
deep learning that has been used for clinical practice13 can clearly visualise OCTA images. However, the reliability 
of denoised OCTA images has not been shown in mCNV.
This study compares single OCTA mCNV images from before and after the denoising process and results 
of averaging multiple images to assess whether the denoising process was clinically useful for depicting mCNV.
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Methods
This prospective, observational, case-series study was approved by the ethics committee of the Kyoto University 
Graduate School of Medicine (Kyoto, Japan). All study protocols adhered to the tenets of the Declaration of 
Helsinki and its later amendments. The nature of the study and possible risks and benefits of participation were 
explained to all study candidates. All individuals who agreed to participate provided written informed consent.
participants. This study included consecutive patients with highly myopic eyes (defined by a spherical 
equivalent ≤ −6.00 dioptres and/or an axial length (AL) ≥ 26 mm) with mCNV, who visited the Department of 
Ophthalmology and Visual Sciences at Kyoto University Graduate School of Medicine (Kyoto, Japan) between 
November 2017 and September 2019. All patients underwent a comprehensive ophthalmologic examination 
including autorefractometry, measurement of best-corrected visual acuity with a decimal visual acuity chart 
(Landolt chart), AL measurement by partial coherence interferometry (IOLMaster, Carl Zeiss Meditec, Inc, 
Dublin, CA), indirect ophthalmoscopy, slit-lamp biomicroscopy, colour fundus photography (TRC-NW8F; 
Topcon Corp, Tokyo, Japan), spectral domain optical coherence tomography (SD-OCT; Spectralis HRA + OCT; 
Heidelberg Engineering, Heidelberg, Germany), fundus fluorescein angiography (FA), fundus indocyanine green 
angiography (ICGA; HRA II; Heidelberg Engineering), and OCTA (OCT-HS100; Canon Lifecare Solutions, Inc, 
Tokyo, Japan) with a maximum 10 images being averaged; this image maximum is more than the images averaged 
(5 images) in a previous study12. Retinal specialists diagnosed mCNV using SD-OCT, FA, and ICGA data. The 
inclusion criteria were a clinical diagnosis of mCNV and mCNV presence determined using averaged OCTA 
images by a retinal specialist (MM). The exclusion criteria were OCTA images of poor quality that hindered 
image analysis including significant segmentation errors and motion artefacts and the presence of other eye dis-
eases including epiretinal membrane and vitreomacular traction syndrome. When both eyes of a patient were 
eligible, the right eye was selected for analysis.
Quantitative assessment of octA images. All OCTA images were acquired using the macular cube 
(3 × 3 mm) protocol of the OCT-HS 100 scanner containing 232 × 232 A-scans. The built-in software automat-
ically performed layer segmentation; the en face image of outer-retina-to-choriocapillaris (ORCC) layer was 
obtained with the inner and outer boundaries at the outer border of the outer plexiform layer and 8 μm beneath 
the Bruch’s membrane, respectively, as previously reported14. Three types of OCTA images were prepared for 
analysis in each participant (Fig. 1): (1) the first single image before the built-in denoising process was accom-
plished by deep learning with image augmentation (detailed information is undisclosed) undertaken with the 
built-in software of OCT-HS100 (single group), (2) the first single image after the denoising process (denoising 
Figure 1. Representative optical coherence tomography angiography (OCTA) images of myopic choroidal 
neovascularisation (mCNV) after denoising and averaging processes. Images of a 76-year-old female patient 
(A–C) and a 60-year-old female patient (D–F) with mCNV in the right and left eyes, respectively. (A,D) Single 
OCTA images before the denoising process are shown. (B,E) Single OCTA images after the denoising process 
are shown. (C,F) OCTA images after the averaging process with a maximum of 10 single images are shown. The 
denoising process allowed for mCNV visualisation with a high contrast.
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group), and (3) averaged images from a maximum of 10 images (averaging group). When the first single image 
quality was poor, the second or third single image was selected.
In OCTA en face images of the ORCC layer, the parameters of vessel density (VD), VLD, vessel diameter 
index (VDI), and FD that represent the CNV status were measured for images from individuals in the 3 groups 
using open-source software (ImageJ, National Institutes of Health, Bethesda, MD) in accordance with a previ-
ous report8. Briefly, once the CNV lesion was manually cropped, the VD was defined as the ratio (%) of the area 
occupied by vessels after binarisation by local thresholding with the Otsu method. The VLD value was defined 
as the ratio (%) of the area occupied by skeletonised vessels after skeletonisation (Fig. 2)9,15,16. The VDI value was 
calculated using the following formula:
= ×VDI (VD/VLD) Littmann’s coefficient,
where VDI represents the average vessel calibre. FD was calculated by measuring the degree of pattern complexity 
by the box-counting method that determines vessel complexity, as described previously15,17. The absolute value of 
VDI required Littmann’ correction18. These OCTA-derived parameters would demonstrate the visible vascularity 
of CNV.
Detectability indices of choroidal neovascularisation. To evaluate CNV detectability indexes, we 
assessed the contrast-to-noise ratio (CNR) and CNV diagnostic scores for images of three groups. Although the 
foveal avascular zone is generally used as the background in CNR analyses for vascular flow in the superficial 
and deep capillary plexus layers11, avascular sites such as the foveal avascular zone are absent in the ORCC layer. 
Therefore, the darkest area around the CNV area was designated as the background and the whole CNV area 
was defined as the foreground (Fig. 3). The same background and foreground sites were selected in 3 individual 
images. Mean grey values and their standard deviations were analysed using ImageJ and the CNR was calculated 
as follows:
δ δ= − +f bCNR ( )/ ,f b
2 2
where f and b are the mean grey values of the foreground and background, respectively, and δf and δb are their 
standard deviations, respectively. When the CNR is high, the CNV area has a higher contrast than that of the area 
around it; thus, a CNV area with a high CNR is thought to be more detectable than a CNV area with a low CNR.
Two blinded retinal specialists (YK and SK) individually and subjectively randomly assessed CNV presence 
without information whether mCNV was present. The subjective assessments consisted of CNV diagnostic scores 
that were categorised as follows: 0 = no CNV, 1 = CNV suspicion, and 2 = CNV presence. When the investigator 
Figure 2. Representative optical coherence tomography angiography (OCTA) images of myopic choroidal 
neovascularisation (mCNV) before and after cropping, binarisation, and skeletonisation. Images of a 76-year-
old female patient (A–D) and a 60-year-old female patient (E–H) with mCNV in the right and left eyes, 
respectively. (A,E) Original single OCTA images before the denoising process are shown. (B,F) Cropped OCTA 
images demonstrating the neovascular lesion are shown. (C,G) Binarised images, used for calculating the vessel 
density (VD), are depicted that show the entire neovascular lesion. (D,H) Skeletonised images were used to 
calculate the vessel length density (VLD) and fractal dimension (FD). Vessel diameter index (VDI) values were 
calculated using VD and VLD. (A–D) The values of VD, VLD, VDI, and FD were 34.1%, 11.5%, 31.1, and 1.5, 
respectively. (E–H) The VD, VLD, VDI, and FD values were 37.3%, 13.9%, 28.3, and 1.6, respectively.
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(MM) found that each score differed considerably between the 2 investigators, a reassessment was conducted 
until the difference of scores fell within 1. Thus, the mean scores from 2 investigators were used for analysis. Taken 
together, the CNV diagnostic scores imply total subjective judgement of CNV presence from factors includ-
ing visible vascularity of CNV (OCTA-derived parameters) and differences between CNV and its surroundings 
(CNR).
Sub-analysis of measurement time. The time that a healthy person fixes his/her face on the OCTA 
device during a single scan and 10 scans for 1 eye as well as the time required for the denoising process and aver-
aging after scanning were measured.
Statistical analysis. Data are presented as the mean ± the standard deviation where applicable. All statisti-
cal analyses were undertaken in using SPSS (version 21; IBM, Armonk, NY). Statistical comparisons among the 3 
groups were conducted using an analysis of variance with repeated measures; subsequent pairwise comparisons 
were undertaken with a Bonferroni test. P-values < 0.05 were considered statistically significant.
Results
Twenty eyes of 20 patients met the inclusion criteria (15 women; 66.9 ± 12.4 years). The AL and refractive errors 
of all patients were 28.41 ± 1.27 mm and −6.66 ± 4.67 dioptres, respectively. Nine patients (45%) had under-
gone intraocular lens implantation after cataract surgery, although the remainder of patients had not. There were 
significant differences in VD, VLD, VDI, FD, CNR, and CNV diagnostic scores among the 3 groups (Table 1). 
Pairwise comparisons in OCTA-derived parameters show that VD, VLD, and FD were higher in the single group 
than in the denoising and averaging groups. The VDI was lower in the single group than in the denoising and 
averaging groups. With regard to CNV detectability indices, CNR and CNV diagnostic scores were higher in the 
Figure 3. A representative image for selecting the foreground and background areas. Image of a 76-year-old 
female patient with myopic choroidal neovascularisation (mCNV) in the right eye. Foreground (within the 
yellow line) and background (within the red line) areas were selected to calculate the contrast-to-noise ratio 










P-value of pairwise comparisons
G1 vs G2 G1 vs G3 G2 vs G3
VD, % 33.4 ± 8.3 29.7 ± 9.3 26.0 ± 12.1 <0.001* <0.001* <0.001* 0.004*
VLD, % 11.9 ± 2.9 9.0 ± 3.0 7.7 ± 3.8 <0.001* <0.001* <0.001* 0.03*
VDI 31.7 ± 5.1 37.6 ± 6.7 40.2 ± 9.9 0.001* <0.001* 0.002* 0.66
FD 1.5 ± 0.1 1.4 ± 0.1 1.3 ± 0.3 <0.001* <0.001* 0.004* 0.61
CNR 1.2 ± 0.3 1.7 ± 0.4 1.5 ± 0.3 <0.001* <0.001* <0.001* 0.03*
CNV diagnostic scores 0.8 ± 0.6 1.3 ± 0.6 1.6 ± 0.4 <0.001* 0.008* <0.001* 0.12
Table 1. Comparison of parameters analysed from optical coherence tomography angiography images. 
Data are presented as the mean ± the standard deviation. VD = vessel density; VLD = vessel length density; 
VDI = vessel diameter index; FD = fractal dimension; CNR = contrast-to-noise ratio; CNV = choroidal 
neovascularization. Statistical comparisons were conducted among the three groups using an analysis of 
variance with repeated measures; subsequent pairwise comparisons were conducted with a Bonferroni test. 
*Statistically significant P < 0.05.
5Scientific RepoRtS |         (2020) 10:6172  | https://doi.org/10.1038/s41598-020-62607-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
denoising and averaging groups than in the single group. There were no significant differences in VDI, FD, or 
CNV diagnostic scores between the denoising and averaging groups. Data for these comparisons are described 
in Table 1.
The time that a 28-year-old healthy female individual fixed her face on the OCTA device at a single scan for 
1 eye was approximately 5 seconds and the time for 10 scans was approximately 248 seconds, although the time 
would vary in accordance with individual patient status. The actual time of the denoising and averaging processes 
after scanning was 5 and 24 seconds, respectively.
Discussion
The present findings demonstrate that the built-in denoising process accomplished by deep learning improved the 
quality of single OCTA images of mCNV in all OCTA-derived parameters and CNV detectability indices in this 
study; furthermore, single denoised OCTA images could be used in lieu of averaged images. As it takes longer to 
obtain OCTA images via the averaging process than to obtain single images, the denoising process can decrease 
the burden on patients and examiners as it only requires 1 image.
In the present study, denoising accomplished by deep learning lowered VD, VDI, and FD, but increased VLD 
in mCNV; these trends are similar with the averaging results. Moreover, on OCTA images of mCNV, CNV vessels 
became sharp and had low pattern complexity after the denoising and averaging processes. As a result, the denois-
ing and averaging processes presented CNV vessels as distinct from normal vessels. Thus, the denoising process 
is useful for detecting mCNV using a single OCTA image.
Biomicroscopic features of mCNV include a light-coloured lesion with a dark and hyperpigmented rim19. 
Therefore, the CNV detectability index included CNR in the present study with the CNV area as the foreground 
and the darkest sites around the CNV area as the background. The CNR values were higher in the denoising 
group than in the single and averaging groups. The OCTA images of mCNV after the denoising process had 
a high contrast between the CNV area and the dark rim around the CNV area. Furthermore, CNV diagnostic 
scores were higher in the denoising group than in the single group; there were no significant differences between 
the denoising and averaging groups. Thus, in clinical practice for mCNV detection, a denoising process is useful 
in a manner similar to that of averaging.
Artificial intelligence with deep learning technology has recently played an important role in diagnosis and 
treatment, health management, drug research and development, and precision medicine13. In ophthalmology, 
some researchers report that deep learning can support an automatic diagnosis of glaucomatous optic neurop-
athy, diabetic retinopathy, and central serous chorioretinopathy20–22. Furthermore, nonperfused areas could be 
automatically detected using deep learning23. In the present study, mCNV on single OCTA images could be 
depicted more clearly using an automatic denoising process that was accomplished by deep learning than by 
single OCTA images before the denoising process. In the future, deep learning technology will likely spread to 
various operations in ophthalmology.
The present study has some limitations. First, the sample size was small. Eleven eyes of 11 patients with aver-
aged OCTA images of poor quality could not be analysed and were excluded. Improvements to OCTA devices 
are necessary in parallel with improvements in deep learning technology. Second, the cropping procedure of the 
CNV area using ImageJ was manually executed. However, because the CNV border is often clear in mCNV, a pre-
vious report also used a manual cropping procedure8. Third, the background for the CNR assessment was manu-
ally selected; we could not automatically select the whole area while excluding the CNV area. However, due to the 
mean grey value of the background included in normal vessels, the value was inadequate to distinguish the dark 
rim around the mCNV region19. To avoid bias, the same sites were selected in all 3 groups in each participant. 
Fourth, since denoised mCNV OCTA images are altered (not original), the possibility that the images might not 
appear to be true CNV images was a concern. However, the denoising process did not produce any unexpected 
images. Fifth, 2 investigators did not assess CNV diagnostic scores of OCTA images without mCNV. Thus, there 
may have been a bias in the CNV diagnostic scores.
In conclusion, a novel built-in denoising process accomplished by deep learning can create single OCTA 
images similar to that of averaged OCTA images. This process is clinically useful to shorten examination times 
whereas providing results of similar quality as obtained with averaging.
Data availability
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